Developer docs
API playgroundTry for free, no card

Search company profiles

Synecor

Full company profile

uuid0009gej

Namestring
Synecor
Websiteurl
synecor.com
Company typeenum
Private
Founded yearint
2000
Descriptiontext

Synecor is a privately held, for-profit entity headquartered in Chapel Hill, North Carolina, founded in 2000. The firm describes itself as having emerged from several synergistic strategic relationships originally centered on interventional cardiology. Beyond this stated origin, no detailed functional description, product portfolio, or service offerings are disclosed in the available data; the company's website (synecor.com) is not accessible and resolves only to a verification/loading page. Leadership is anchored by CEO and co-founder William Starling, with no additional management team information available in the provided sources.

The firm operates with a very small team (1-10 employees), and the available record shows two financing events — one from Asset Management Ventures (AMV) in May 2013 and one from Synergy Life Science Partner in January 2020 — both with undisclosed funding amounts. There are no recorded products, customers, pricing models, partnerships, acquisitions, or revenue data in the input. The combination of a multi-decade operating history, life sciences investor participation, original interventional cardiology focus, and extremely small headcount suggests Synecor may function as a strategic vehicle for incubation, spin-out formation, or specialized venture activity in the medical device space rather than as a scaled operating company, though this characterization cannot be confirmed from the available evidence.

No go-to-market motion, revenue mechanics, customer segments, or distribution channels have been disclosed. The absence of marketing channels, app, API, or integration footprint indicates limited observable commercial activity. Overall, the data describes a long-standing but extremely lean private entity with cardiac medical roots and a sparse public footprint.

Short descriptiontext

Synecor is a privately held, Chapel Hill-based entity founded in 2000 that originated from strategic relationships in interventional cardiology, operating with a 1-10 person team under co-founder and CEO William Starling.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersChapel Hill, United States
HQ citystring
Chapel Hill
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Keyword5 values
interventional cardiology, medical devices, cardiovascular implants, cardiac therapy devices, minimally invasive cardiology
Industry1 code
PRIMARYHLAHAFAL
Cardiac Assist & Heart Failure Therapies (Implantables, Neuromodulation)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Cardiovascular Devices (Stents, Valves, Rhythm Management)
NAICS code1 code
  • Scientific Research and Development Services5417
Product category
Interventional Cardiology Medical Devices
No data
Cost components5 values
Technology or R&D, Personnel, Operations, Supply Chain, Others
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

Synecor is a medical device company operating in the field of interventional cardiology, formed from the convergence of synergistic strategic relationships. The company develops and advances cardiovascular therapy products, including implants and minimally invasive devices, targeting structural heart and related interventional cardiology applications. Its activities center on bringing next-generation interventional cardiology technologies to clinical use.

Differentiator
Functional benefit
Problem solved
Recent move2 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight1 record

Each record includes

Type, Description

Peers8 records
TypeDirect peer
Description

The Foundry is a medical device incubator based in the San Francisco Bay Area that creates, funds, and operates early-stage device companies — the closest direct analogue to Synecor's venture-creation model, including cardiovascular programs.

TypeDirect peer
Description

InCube Labs is a life-sciences incubator founded by Mir Imran that builds and spins out medical device and therapeutic companies, sharing Synecor's founder-led incubator approach and cardiovascular device exposure.

TypeDirect peer
Description

ExploraMed is a medical device incubator founded by Dr. Josh Makower that has created multiple device ventures, including in interventional and minimally invasive therapy — directly comparable in business model to Synecor.

TypeDirect peer
Description

TauTona Group is a medical device accelerator that incubates early-stage device companies with a hands-on operational model similar to Synecor's, focused on rapidly advancing concepts toward clinical and commercial milestones.

TypeDirect peer
Description

The Fogarty Institute is a nonprofit medical device incubator that mentors and funds early-stage device entrepreneurs, sharing Synecor's model of nurturing small device teams from concept through clinical development.

TypeBroad incumbent
Description

Edwards Lifesciences is a global leader in interventional cardiology and structural heart devices, representing the broad incumbent endpoint for cardiovascular device innovation that Synecor's portfolio companies could feed into or partner with.

TypeBroad incumbent
Description

Medtronic is one of the largest interventional cardiology and cardiac device incumbents globally, serving as a strategic acquirer and channel for early-stage cardiovascular technologies incubated by firms like Synecor.

8Abbott Laboratories
TypeBroad incumbent
Description

Abbott operates one of the broadest cardiovascular and interventional cardiology portfolios and is a frequent acquirer of early-stage device assets, making it a comparable incumbent endpoint for Synecor-style incubators.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat2 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights4 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds2 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors2 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment1 record

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Synecor

Interventional Cardiology Medical Devicessynecor.com

Synecor is a privately held, Chapel Hill-based entity founded in 2000 that originated from strategic relationships in interventional cardiology, operating with a 1-10 person team under co-founder and CEO William Starling.

What Synecor does

Synecor is a privately held, for-profit entity headquartered in Chapel Hill, North Carolina, founded in 2000. The firm describes itself as having emerged from several synergistic strategic relationships originally centered on interventional cardiology. Beyond this stated origin, no detailed functional description, product portfolio, or service offerings are disclosed in the available data; the company's website (synecor.com) is not accessible and resolves only to a verification/loading page. Leadership is anchored by CEO and co-founder William Starling, with no additional management team information available in the provided sources.

The firm operates with a very small team (1-10 employees), and the available record shows two financing events — one from Asset Management Ventures (AMV) in May 2013 and one from Synergy Life Science Partner in January 2020 — both with undisclosed funding amounts. There are no recorded products, customers, pricing models, partnerships, acquisitions, or revenue data in the input. The combination of a multi-decade operating history, life sciences investor participation, original interventional cardiology focus, and extremely small headcount suggests Synecor may function as a strategic vehicle for incubation, spin-out formation, or specialized venture activity in the medical device space rather than as a scaled operating company, though this characterization cannot be confirmed from the available evidence.

No go-to-market motion, revenue mechanics, customer segments, or distribution channels have been disclosed. The absence of marketing channels, app, API, or integration footprint indicates limited observable commercial activity. Overall, the data describes a long-standing but extremely lean private entity with cardiac medical roots and a sparse public footprint.

Synecor firmographics

Firmographics
Name
Synecor
Website
https://synecor.com
Company type
Private
Founded year
2000
Operating status
Operating
Headcount range
1–10 employees
Short description
Synecor is a privately held, Chapel Hill-based entity founded in 2000 that originated from strategic relationships in interventional cardiology, operating with a 1-10 person team under co-founder and CEO William Starling.
Ownership category
akta.pro rank

Synecor industry classification

Industry
Product category
Interventional Cardiology Medical Devices
NAICS
Scientific Research and Development Services (5417)
akta.pro industry
PRIMARYHLAHAFAL
Cardiac Assist & Heart Failure Therapies (Implantables, Neuromodulation)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Cardiovascular Devices (Stents, Valves, Rhythm Management)

Keywords

  • Interventional cardiology
  • Medical devices
  • Cardiovascular implants
  • Cardiac therapy devices
  • Minimally invasive cardiology

Where Synecor is headquartered

Location

Headquarters

HQ city
Chapel Hill
HQ country
United States
HQ region
North America

Markets served

Synecor business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Technology or R&D, Personnel, Operations, Supply Chain, Others

Synecor product offering

Product offering

Core offering

Synecor is a medical device company operating in the field of interventional cardiology, formed from the convergence of synergistic strategic relationships. The company develops and advances cardiovascular therapy products, including implants and minimally invasive devices, targeting structural heart and related interventional cardiology applications. Its activities center on bringing next-generation interventional cardiology technologies to clinical use.

Differentiator

Problem solved

Functional benefit

Companies that use Synecor

Customer profile

Ideal customer profiles1 record

Synecor technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Synecor partnerships and signals

Strategic signal

Recent moves2 records

Expansion highlights1 record

Synecor competitors and assessment

Company assessment

Direct peers

  • The Foundry: The Foundry is a medical device incubator based in the San Francisco Bay Area that creates, funds, and operates early-stage device companies — the closest direct analogue to Synecor's venture-creation model, including cardiovascular programs.
  • InCube Labs: InCube Labs is a life-sciences incubator founded by Mir Imran that builds and spins out medical device and therapeutic companies, sharing Synecor's founder-led incubator approach and cardiovascular device exposure.
  • ExploraMed: ExploraMed is a medical device incubator founded by Dr. Josh Makower that has created multiple device ventures, including in interventional and minimally invasive therapy — directly comparable in business model to Synecor.
  • TauTona Group: TauTona Group is a medical device accelerator that incubates early-stage device companies with a hands-on operational model similar to Synecor's, focused on rapidly advancing concepts toward clinical and commercial milestones.
  • Fogarty Institute for Innovation: The Fogarty Institute is a nonprofit medical device incubator that mentors and funds early-stage device entrepreneurs, sharing Synecor's model of nurturing small device teams from concept through clinical development.

Broad incumbents

  • Edwards Lifesciences: Edwards Lifesciences is a global leader in interventional cardiology and structural heart devices, representing the broad incumbent endpoint for cardiovascular device innovation that Synecor's portfolio companies could feed into or partner with.
  • Medtronic: Medtronic is one of the largest interventional cardiology and cardiac device incumbents globally, serving as a strategic acquirer and channel for early-stage cardiovascular technologies incubated by firms like Synecor.
  • Abbott Laboratories: Abbott operates one of the broadest cardiovascular and interventional cardiology portfolios and is a frequent acquirer of early-stage device assets, making it a comparable incumbent endpoint for Synecor-style incubators.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat2 records

Key risks5 records

Key highlights4 records

Customer concentration

Synecor financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Synecor leadership team

Management profile

Number of profiles

Profiles1 record

Synecor funding detail

Funding detail

Funding overview

Funding rounds2 records

Investors2 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Synecor M&A and investment

M&A and investment

M&A

Investments1 record

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Synecor

What does Synecor do?

Synecor is a medical device company operating in the field of interventional cardiology, formed from the convergence of synergistic strategic relationships. The company develops and advances cardiovascular therapy products, including implants and minimally invasive devices, targeting structural heart and related interventional cardiology applications. Its activities center on bringing next-generation interventional cardiology technologies to clinical use.

Is Synecor a public or private company?

Synecor is a private company. It is classified as venture growth investor backed and is currently operating.

When was Synecor founded?

Synecor was founded in 2000. It employs 1 to 10 people.

Where is Synecor based?

Synecor is headquartered in Chapel Hill, United States, in the North America region.

Who are Synecor's main competitors?

Direct peers on record are The Foundry, InCube Labs, ExploraMed, TauTona Group and Fogarty Institute for Innovation. Broad incumbents are Edwards Lifesciences, Medtronic and Abbott Laboratories.

Does Synecor have an API?

No public API is recorded for Synecor.

What industry is Synecor in?

Synecor's product category is Interventional Cardiology Medical Devices. Its primary akta.pro industry code is HLAHAFAL, Cardiac Assist & Heart Failure Therapies (Implantables, Neuromodulation). Its NAICS code is 5417.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals